Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Roflumilast, a type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis
In this open-label, randomized, controlled trial, 1,323 men and women with a mean age of 83 were either switched from warfarin to a DOAC (662 patients) or left on warfarin (661 patients)
Nutrients , 13(10), p.3432
If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team
These factors do not equate to visible muscle gain
US$ 25.73
US$ 28.21
US$ 20.01
US$ 24.45
US$ 20.04
